Orchestra BioMed Holdings (OBIO) Non Operating Income (2023 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Non Operating Income of -$821000.0 for Q1 2026, down 594.58% year-over-year from $166000.0 in Q1 2025, and down 7.6% quarter-over-quarter from -$763000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Non Operating Income (2023 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Non Operating Income for 4 consecutive years, with -$821000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 594.58% year-over-year to -$821000.0; the TTM figure through Mar 2026 stood at -$2.1 million (down 185.2% YoY), while the FY2025 annual figure was -$1.1 million, down 134.21% from the prior year.
- Non Operating Income eased to -$821000.0 in Q1 2026 per OBIO's latest filing, from -$763000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $1.1 million in Q4 2023 and bottomed at -$821000.0 in Q1 2026.
- Historically, Non Operating Income has averaged $310000.0 across 4 years, with a median of $522000.0 in 2024.
- Annual changes were most pronounced in 2024 — Non Operating Income rose 0.11% — and 2026, when it tumbled 594.58%.
- Orchestra BioMed Holdings' Non Operating Income stood at $1.1 million in 2023, then slumped by 52.89% to $522000.0 in 2024, then tumbled by 246.17% to -$763000.0 in 2025, then fell by 7.6% to -$821000.0 in 2026.
- Business Quant data shows OBIO's Non Operating Income at -$821000.0 in Q1 2026, -$763000.0 in Q4 2025, and -$515000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.77 Mn |
| Mar 31, 2026 | -821,000.00 |
| Dec 31, 2025 | -763,000.00 |
| Sep 30, 2025 | -515,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 916,000.00 |
| Jun 30, 2024 | 902,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 915,000.00 |